Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Preventive and therapeutic types of environmental enrichment counteract beta amyloid pathology by different molecular mechanisms 2011-03-22
  2. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution 1995-03-01

Studies

2 studies carry this tag.

Date range

1995 to 2011

Top journals

  • Journal of neuropathology and experimental neurology 1
  • Neurobiology of disease 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Preventive and therapeutic types of environmental enrichment counteract beta amyloid pathology by different molecular mechanisms

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurobiology of disease 2011-03-22 Biomarkers

    Combined preventive and therapeutic physical/cognitive stimulation starting before disease onset and continuing over its progression reduce Alzheimer-related pathology in transgenic mice.

  2. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neuropathology and experimental neurology 1995-03-01 Risk genes beyond APOE

    The histologically apparent polymorphism of plaques containing beta-amyloid in Alzheimer's disease is thought to represent different stages in plaque evolution. beta-amyloid-immunopositive plaques were classified according to the pattern of beta-amyloid distribution (diffuse vs dense-core) and the presence or absence of dystrophic beta-amyloid precursor protein-immunopositive (beta-APP+) neurites (neuritic vs non-neuritic).

All topic tags with their study counts